Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 5 minute read Pharma Industry News PDS Biotechnology Corporation strengthens PDS0101 intellectual property ahead of key regulatory milestones PDS Biotechnology strengthens PDS0101 patent protection ahead of key Phase 3 and regulatory milestones. Find out what this means for investors. bySoujanya RaviJanuary 25, 2026